ICCC

Greater Fort Dodge Growth Alliance Celebrates the Diversity of Businesses in the Region

Retrieved on: 
金曜日, 7月 8, 2022
Surgeon, Patient, Business, LinkedIn, Community development, Family, Brain, Contact, UnityPoint Health, Community, Health Industry Business Communications Council, UnityPoint Health - Allen Hospital, Partnership, YouTube, Economic development, ICCC, Elective surgery, Fort Dodge, Iowa, Communication, Twitter, Muscle, Joint, Mass communication specialist, Gypsum, Medical device, Oil, Hospital, Facebook, CNOS

FORT DODGE, Iowa, July 8, 2022 /PRNewswire-PRWeb/ -- The series of videos being released from the Greater Fort Dodge Growth Alliance continue to show the diversity of businesses in the region and the third video takes it even a step further by demonstrating the partnerships that are established.

Key Points: 
  • The Greater Fort Dodge Growth Alliance has released a new video series called Business, Community, Opportunity.
  • FORT DODGE, Iowa, July 8, 2022 /PRNewswire-PRWeb/ -- The series of videos being released from the Greater Fort Dodge Growth Alliance continue to show the diversity of businesses in the region and the third video takes it even a step further by demonstrating the partnerships that are established.
  • The Greater Fort Dodge Growth Alliance also encourages the public and our area businesses to freely share the videos as they actively demonstrate the diversity of the businesses and opportunities that are available here.
  • Learn more about the region and the Greater Fort Dodge Growth Alliance at http://www.greaterfortdodge.com or Contact Us .

ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

Retrieved on: 
木曜日, 7月 7, 2022
Efficiency, Review, Immediate, FDA, Decision-making, CEO, Securities Act of 1933, Securities Exchange Act of 1934, CGMP, Grain, Good manufacturing practice, Marketing, COVID-19, Corporation, Company, U.S. Securities and Exchange Commission, Forward-looking statement, Prevalence, Compliance, Income, Drug Quality and Security Act, New Animal Drug Application, Investor, Health, ICCC, SEC, First, Risk, Time, Nature, Recurrence, Interest, Press release, Security (finance), Video game, Risk management

The production capacity estimates referred to in this press release are subject to biological and process yield variances, product format mix, selling price and other factors.

Key Points: 
  • The production capacity estimates referred to in this press release are subject to biological and process yield variances, product format mix, selling price and other factors.
  • Since the first quarter of 2020, the Company has been providing a preliminary look at its top line results soon after the close of the quarter.
  • The Company expects to provide this prompt, preliminary report on product sales until further notice going forward.
  • The Company will host a conference call on Friday, August 12, 2022 at 9:00 AM ET to discuss the full financial results for the quarter ended June 30, 2022.

Pizza Hut Canada's® Equal Slice Program Celebrates Successful First Year, Providing Over 50 Small Business Owners with Training, Education and Mentorship

Retrieved on: 
水曜日, 7月 6, 2022
Research, Education, Batman: Year Two, Initiative, BIPOC, Growth, Goal, Magnet, Employment, Creole, Restaurant, Harvard Business School, Partnership, NYSE, General manager, ICCC, Culture, ICIC, Pizza Hut, Small business, Hearing, Program, Yum, Income, Fast food, Management

"At Pizza Hut, we believe opportunity is meant to be shared, just like pizza," says Tatiana Carrascal, President and General Manager, Pizza Hut Canada.

Key Points: 
  • "At Pizza Hut, we believe opportunity is meant to be shared, just like pizza," says Tatiana Carrascal, President and General Manager, Pizza Hut Canada.
  • "We were inspired to start the Equal Slice Program to support small business owners across Canada and ensure they have access to the education, training and resources they need to succeed.
  • Year One of the Equal Slice Program welcomed more than 50 minority business owners from across Canada.
  • To learn more about Pizza Hut and the Equal Slice Program, and to read about small business owners who participated in the Equal Slice Program, please visit www.PizzaHut.ca /EqualSlice.

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

Retrieved on: 
木曜日, 5月 19, 2022
Income, Company, Good manufacturing practice, Investor, Annual general meeting, U.S. Securities and Exchange Commission, Annual, Annual Meetings of the International Monetary Fund and the World Bank Group, Health, Nature, Grain, CGMP, Decision-making, COVID-19, Marketing, Method, Efficiency, Recurrence, Securities Act of 1933, Securities Exchange Act of 1934, Press release, Time, Forward-looking statement, Compliance, Communication, Safety, Proxy, Risk, Drug Quality and Security Act, First, Q&A, Corporation, Shareholder, Security (finance), ICCC, SEC, Immediate, Prevalence, Annual report, GLOBE, Risk management

The Annual Meeting will take place Wednesday, June 15, 2022, at 3:00 PM ET.

Key Points: 
  • The Annual Meeting will take place Wednesday, June 15, 2022, at 3:00 PM ET.
  • Stockholders, regardless of their plans to attend the virtual-only meeting, are encouraged to vote and submit their proxies in advance of the Annual Meeting using one of the methods described in the proxy materials.
  • Stockholders that would like to vote at the Annual Meeting (instead of by proxy) should contact the Companys Voting Inspector in advance of the meeting at (207) 878-2770 Ext.
  • For more information about the Annual Meeting, including the matters to be voted on during the Annual Meeting, please see the Companys Notice of Annual Meeting of Stockholders and its Proxy Statement, which are available, along with the 2021 Annual Report on Form 10-K, at www.immucell.com .

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022

Retrieved on: 
火曜日, 5月 10, 2022
COVID-19, U.S. Securities and Exchange Commission, Decision-making, First, Forward-looking statement, Interest, GLOBE, ICCC, Company, Securities Exchange Act of 1934, Securities Act of 1933, Time, Prevalence, CGMP, Good manufacturing practice, Security (finance), Grain, Review, Risk, Drug Quality and Security Act, Compliance, Immediate, Press release, Health, Corporation, Marketing, Efficiency, Income, New product development, Investor, SEC, Technology, VP, Recurrence, Nature, Risk management

PORTLAND, Maine, May 10, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2022 after the market closes on Thursday, May 12, 2022.

Key Points: 
  • PORTLAND, Maine, May 10, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2022 after the market closes on Thursday, May 12, 2022.
  • The Company has scheduled a conference call the next morning, Friday, May 13, 2022, at 9:00 AM ET to review the financial results.
  • Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET.
  • The Company expects to file its Quarterly Report on Form 10-Q after the market closes on Thursday, May 12, 2022.

Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

Retrieved on: 
木曜日, 5月 5, 2022
American Veterinary Medical Association, COVID-19, U.S. Securities and Exchange Commission, Communication, Decision-making, First, Forward-looking statement, Interest, DVM, GLOBE, Sustainability, ICCC, Tillamook County Creamery Association, Company, Securities Exchange Act of 1934, Securities Act of 1933, Time, Prevalence, Good manufacturing practice, CGMP, Security (finance), Review, Grain, Risk, Association, Organization, FDA, American Association, Energy Independence and Security Act of 2007, Industry, Compliance, Immediate, Public relations, Press release, Marketing, Health, Corporation, Efficiency, Income, Investor, SEC, Stakeholder engagement, Mentorship, VP, Research, CEO, Recurrence, Nature, Risk management, Management

One of his principal responsibilities for ImmuCell will be to prepare for the launch of Re-Tain, which is subject to FDA approval.

Key Points: 
  • One of his principal responsibilities for ImmuCell will be to prepare for the launch of Re-Tain, which is subject to FDA approval.
  • Marks skillset and network is very well aligned with the primary objectives of this role, indicated Bobbi Brockmann, VP of Sales and Marketing for ImmuCell.
  • He will champion research and communication efforts aimed to bridge the value of Re-Tain from producer to processor.
  • Mark is the right person at the right time for us, added Michael F. Brigham, President and CEO of ImmuCell.

ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022

Retrieved on: 
月曜日, 4月 11, 2022
CGMP, Company, New Animal Drug Application, ICCC, Recurrence, Good manufacturing practice, Grain, Investment, Marketing, Risk, Forward-looking statement, Compliance, SEC, Interest, Investor, CEO, Health, U.S. Securities and Exchange Commission, Prevalence, Press release, First, Review, Securities Exchange Act of 1934, Securities Act of 1933, Time, COVID-19, Income, Drug Quality and Security Act, Nature, Efficiency, FDA, Corporation, Immediate, Security (finance), Decision-making, Video game, Renewable energy, Risk management

During the Twelve-Month Periods Ended March 31,

Key Points: 
  • During the Twelve-Month Periods Ended March 31,
    *Represents a record high level of sales for any quarter with the first quarter being seasonally high for sales.
  • Our 2022 first quarter annualized manufacturing output reached $23.8 million, exceeding the current level of $23 million of annual production capacity that we targeted for the end of 2021.
  • Since the first quarter of 2020, the Company has been providing a preliminary look at its top line results soon after the close of the quarter.
  • The Company will host a conference call on Friday, May 13, 2022 at 9:00 AM ET to discuss the full financial results for the quarter ended March 31, 2022.

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021

Retrieved on: 
水曜日, 2月 16, 2022
First, Health, Income, Time, Marketing, Company, ICCC, Prevalence, Recurrence, SEC, VP, Forward-looking statement, U.S. Securities and Exchange Commission, Review, Security (finance), Investor, Drug Quality and Security Act, Efficiency, Annual report, Decision-making, Securities Exchange Act of 1934, Risk, Compliance, Securities Act of 1933, CGMP, Press release, Investment, Nature, Immediate, COVID-19, Corporation, Interest, Good manufacturing practice, GLOBE, Risk management

The Company has scheduled a conference call the next morning, Wednesday, February 23, 2022, at 9:00 AM ET to review the financial results.

Key Points: 
  • The Company has scheduled a conference call the next morning, Wednesday, February 23, 2022, at 9:00 AM ET to review the financial results.
  • Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET.
  • A teleconference replay of the call will be available for seven days at (877) 344-7529 (toll free) or (412) 317-0088 (international), utilizing confirmation #7112153.
  • ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef calves.

ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021

Retrieved on: 
水曜日, 1月 5, 2022
Time, Press release, ICCC, COVID-19, CGMP, Drug Quality and Security Act, First, Review, Company, Forward-looking statement, Good manufacturing practice, Corporation, Prevalence, Securities Exchange Act of 1934, New Animal Drug Application, Risk, Immediate, U.S. Securities and Exchange Commission, Income, Security (finance), Efficiency, CEO, Health, SEC, Decision-making, Marketing, FDA, Compliance, Securities Act of 1933, Investor, Recurrence, Interest, Nature, Renewable energy, Risk management

Sales for full year 2021 increased by about 25% to $19.2 million compared to full year 2020, which is exciting for us, commented Michael F. Brigham, President and CEO of ImmuCell.

Key Points: 
  • Sales for full year 2021 increased by about 25% to $19.2 million compared to full year 2020, which is exciting for us, commented Michael F. Brigham, President and CEO of ImmuCell.
  • I salute the entire ImmuCell team for having successfully delivered significant year-over-year sales growth in a challenging environment.
  • Our 2021 fourth quarter annualized manufacturing output almost reached the $23 million level targeted for Phase I of our investment to increase manufacturing capacity.
  • The Company will host a conference call on Wednesday, February 23, 2022 to discuss the full financial results for the year ended December 31, 2021.

Global Command and Control Software for CNI, Airports, and Safe Cities 2021: Top 10 Company Profiles

Retrieved on: 
木曜日, 12月 23, 2021
Control center, Organization, CNI, Command, ICCC, Jointness and integration in the Indian military, Brain, Decision-making, Critical infrastructure, Industry, Control software, Video game, Satellite navigation device, Risk management

DUBLIN, Dec. 23, 2021 /PRNewswire/ -- The "Command and Control Software for CNI, Airports, and Safe Cities, Global, 2021: Frost Radar Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 23, 2021 /PRNewswire/ -- The "Command and Control Software for CNI, Airports, and Safe Cities, Global, 2021: Frost Radar Report" report has been added to ResearchAndMarkets.com's offering.
  • Command and control software serves as the brain behind ICCCs that controls, governs, and monitors all connected systems.
  • Command and control software connects multiple discrete systems at various locations and integrates different security applications and equipment on a centralized platform.
  • The global command and control software market spending is forecast to reach $21.41 billion by 2030.